BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Knox NC, Forbes JD, Peterson CL, Van Domselaar G, Bernstein CN. The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases. Am J Gastroenterol. 2019;114:1051-1070. [PMID: 31232832 DOI: 10.14309/ajg.0000000000000305] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Ricciuto A, Sherman PM, Laxer RM. Gut microbiota in chronic inflammatory disorders: A focus on pediatric inflammatory bowel diseases and juvenile idiopathic arthritis. Clinical Immunology 2020;215:108415. [DOI: 10.1016/j.clim.2020.108415] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
2 Ahlawat S, Kumar P, Mohan H, Goyal S, Sharma KK. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Crit Rev Microbiol 2021;47:254-73. [PMID: 33576711 DOI: 10.1080/1040841X.2021.1876631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Glassner KL, Abraham BP, Quigley EMM. The microbiome and inflammatory bowel disease. J Allergy Clin Immunol. 2020;145:16-27. [PMID: 31910984 DOI: 10.1016/j.jaci.2019.11.003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 36.5] [Reference Citation Analysis]
4 Pratt M, Forbes JD, Knox NC, Bernstein CN, Van Domselaar G. Microbiome-Mediated Immune Signaling in Inflammatory Bowel Disease and Colorectal Cancer: Support From Meta-omics Data. Front Cell Dev Biol 2021;9:716604. [PMID: 34869308 DOI: 10.3389/fcell.2021.716604] [Reference Citation Analysis]
5 Nowakowska A, Demkow U, Podsiadły E. Zakażenia przewodu pokarmowego w XXI wieku w Polsce i na świecie. Postępy Higieny i Medycyny Doświadczalnej 2021;75:48-57. [DOI: 10.5604/01.3001.0014.6955] [Reference Citation Analysis]
6 Krela-Kaźmierczak I, Zakerska-Banaszak O, Skrzypczak-Zielińska M, Łykowska-Szuber L, Szymczak-Tomczak A, Zawada A, Rychter AM, Ratajczak AE, Skoracka K, Skrzypczak D, Marcinkowska E, Słomski R, Dobrowolska A. Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review. Nutrients 2022;14:2520. [PMID: 35745251 DOI: 10.3390/nu14122520] [Reference Citation Analysis]
7 Vatn S, Carstens A, Kristoffersen AB, Bergemalm D, Casén C, Moen AEF, Tannaes TM, Lindstrøm J, Detlie TE, Olbjørn C, Lindquist CM, Söderholm JD, Gomollón F, Kalla R, Satsangi J, Vatn MH, Jahnsen J, Halfvarson J, Ricanek P; IBD-Character Consortium. Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character). Scand J Gastroenterol 2020;55:1146-56. [PMID: 32780604 DOI: 10.1080/00365521.2020.1803396] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Pratt M, Forbes JD, Knox NC, van Domselaar G, Bernstein CN. Colorectal Cancer Screening in Inflammatory Bowel Diseases-Can Characterization of GI Microbiome Signatures Enhance Neoplasia Detection? Gastroenterology 2022:S0016-5085(22)00007-5. [PMID: 34998802 DOI: 10.1053/j.gastro.2021.12.287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Li Q, Zhou S, Wang Y, Cong J. Changes of intestinal microbiota and microbiota-based treatments in IBD. Arch Microbiol 2022;204:442. [PMID: 35776212 DOI: 10.1007/s00203-022-03069-4] [Reference Citation Analysis]
10 Chai R, Tai Z, Zhu Y, Chai C, Chen Z, Zhu Q. Symbiotic microorganisms: prospects for treating atopic dermatitis. Expert Opin Biol Ther 2022;:1-17. [PMID: 35695265 DOI: 10.1080/14712598.2022.2089560] [Reference Citation Analysis]
11 Wang Z, Yu Y, Liao J, Hu W, Bian X, Wu J, Zhu YZ. S-Propargyl-Cysteine Remodels the Gut Microbiota to Alleviate Rheumatoid Arthritis by Regulating Bile Acid Metabolism. Front Cell Infect Microbiol 2021;11:670593. [PMID: 34422677 DOI: 10.3389/fcimb.2021.670593] [Reference Citation Analysis]
12 Zhang Y, Si X, Yang L, Wang H, Sun Y, Liu N. Association between intestinal microbiota and inflammatory bowel disease. Animal Model Exp Med 2022. [PMID: 35808814 DOI: 10.1002/ame2.12255] [Reference Citation Analysis]
13 Feng S, Meng C, Hao Z, Liu H. Bacillus licheniformis Reshapes the Gut Microbiota to Alleviate the Subhealth. Nutrients 2022;14:1642. [PMID: 35458204 DOI: 10.3390/nu14081642] [Reference Citation Analysis]
14 Sikora M, Stec A, Chrabaszcz M, Knot A, Waskiel-Burnat A, Rakowska A, Olszewska M, Rudnicka L. Gut Microbiome in Psoriasis: An Updated Review. Pathogens 2020;9:E463. [PMID: 32545459 DOI: 10.3390/pathogens9060463] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
15 Yang ZH, Liu F, Zhu XR, Suo FY, Jia ZJ, Yao SK. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World J Gastroenterol 2021; 27(24): 3609-3629 [PMID: 34239273 DOI: 10.3748/wjg.v27.i24.3609] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
16 Algieri F, Garrido-Mesa J, Vezza T, Rodríguez-Sojo MJ, Rodríguez-Cabezas ME, Olivares M, García F, Gálvez J, Morón R, Rodríguez-Nogales A. Intestinal anti-inflammatory effects of probiotics in DNBS-colitis via modulation of gut microbiota and microRNAs. Eur J Nutr 2021;60:2537-51. [PMID: 33216193 DOI: 10.1007/s00394-020-02441-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kang K, Sun Y, Li YL, Chang B. Pathogenesis of liver injury in Takayasu arteritis: advanced understanding leads to new horizons. J Int Med Res 2020;48:300060520972222. [PMID: 33275473 DOI: 10.1177/0300060520972222] [Reference Citation Analysis]
18 Barbiellini Amidei C, Comoretto R, Zanier L, Donà D, Cantarutti A, Canova C. Acid-suppressive medications in the first year of life and risk of childhood asthma: a population-based birth cohort study. Eur Respir J 2020;56:2000197. [PMID: 32499332 DOI: 10.1183/13993003.00197-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Cantarutti A, Barbiellini Amidei C, Valsecchi C, Scamarcia A, Corrao G, Gregori D, Giaquinto C, Ludvigsson JF, Canova C. Association of Treated and Untreated Gastroesophageal Reflux Disease in the First Year of Life with the Subsequent Development of Asthma. Int J Environ Res Public Health 2021;18:9633. [PMID: 34574556 DOI: 10.3390/ijerph18189633] [Reference Citation Analysis]
20 Gayathri KV, Aishwarya S, Kumar PS, Rajendran UR, Gunasekaran K. Metabolic and molecular modelling of zebrafish gut biome to unravel antimicrobial peptides through metagenomics. Microb Pathog 2021;154:104862. [PMID: 33781870 DOI: 10.1016/j.micpath.2021.104862] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Barrea L, Megna M, Cacciapuoti S, Frias-Toral E, Fabbrocini G, Savastano S, Colao A, Muscogiuri G. Very low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: an update for dermatologists and nutritionists. Crit Rev Food Sci Nutr 2020;:1-17. [PMID: 32969257 DOI: 10.1080/10408398.2020.1818053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Abed OA, Attlassy Y, Xu J, Han K, Moon JJ. Emerging Nanotechnologies and Microbiome Engineering for the Treatment of Inflammatory Bowel Disease. Mol Pharm 2022. [PMID: 35878420 DOI: 10.1021/acs.molpharmaceut.2c00222] [Reference Citation Analysis]
23 Seidelin JB, Bahl MI, Licht TR, Mead BE, Karp JM, Johansen JV, Riis LB, Galera MR, Woetmann A, Bjerrum JT. Acute Experimental Barrier Injury Triggers Ulcerative Colitis-Specific Innate Hyperresponsiveness and Ulcerative Colitis-Type Microbiome Changes in Humans. Cell Mol Gastroenterol Hepatol 2021:S2352-345X(21)00117-X. [PMID: 34118489 DOI: 10.1016/j.jcmgh.2021.06.002] [Reference Citation Analysis]
24 Li X, Ren Y, Zhang J, Ouyang C, Wang C, Lu F, Yin Y. Development of Early-Life Gastrointestinal Microbiota in the Presence of Antibiotics Alters the Severity of Acute DSS-Induced Colitis in Mice. Microbiol Spectr 2022;:e0269221. [PMID: 35438531 DOI: 10.1128/spectrum.02692-21] [Reference Citation Analysis]
25 Bernstein CN, Kuenzig ME, Coward S, Nugent Z, Nasr A, El-Matary W, Singh H, Kaplan GG, Benchimol EI. Increased Incidence of Inflammatory Bowel Disease After Hirschsprung Disease: A Population-based Cohort Study. J Pediatr 2021;233:98-104.e2. [PMID: 33545193 DOI: 10.1016/j.jpeds.2021.01.060] [Reference Citation Analysis]
26 Boros É, Prontvai B, Kellermayer Z, Balogh P, Sarlós P, Vincze Á, Varga C, Maróti Z, Bálint B, Nagy I. Transcriptome Based Profiling of the Immune Cell Gene Signature in Rat Experimental Colitis and Human IBD Tissue Samples. Biomolecules 2020;10:E974. [PMID: 32610492 DOI: 10.3390/biom10070974] [Cited by in F6Publishing: 1] [Reference Citation Analysis]